Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus

Publication date: Available online 16 August 2018

Source: Clinical Immunology

Author(s): Anastasia Tsanaktsi, Elena E. Solomou, Stamatis-Nick C. Liossis

Abstract

Skewed cytokine production characterizes T cells in Systemic Lupus Erythematosus (SLE). Among Th17 cells that are expanded in lupus, a subset (Th1/17) retains the ability to produce IFNγ.

We aimed to analyze Th17 and Th1/17 cells in patients with SLE. Patients with active disease displayed increased percentages of circulating Τh17 and Th1/17 cells. Stimulated T cells from patients with lupus secreted significantly more IL-17 compared to healthy donors.

Also, T cells from patients with active SLE released significantly lower levels of IFN-γ compared to controls. However, following stimulation, levels of IFN-γ also rose significantly. Our data suggest that lupus Th1/17 cells are not only expanded but also functional.

In summary, in this study it was shown that patients with active SLE display increased Th17 and functional Th1/17 cells. This impaired T-cell axis might represent a possible future therapeutic target.

https://ift.tt/2MRuNwc